DK2809810T3 - System og fremgangsmåde til påvisning i perifert blod af rna'er der er forandret af lungecancer - Google Patents

System og fremgangsmåde til påvisning i perifert blod af rna'er der er forandret af lungecancer Download PDF

Info

Publication number
DK2809810T3
DK2809810T3 DK13733697.0T DK13733697T DK2809810T3 DK 2809810 T3 DK2809810 T3 DK 2809810T3 DK 13733697 T DK13733697 T DK 13733697T DK 2809810 T3 DK2809810 T3 DK 2809810T3
Authority
DK
Denmark
Prior art keywords
perferral
blood
detecting
lung cancer
modified rnas
Prior art date
Application number
DK13733697.0T
Other languages
English (en)
Inventor
Scott Morris
David Mallery
Original Assignee
Viomics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Viomics Inc filed Critical Viomics Inc
Application granted granted Critical
Publication of DK2809810T3 publication Critical patent/DK2809810T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
DK13733697.0T 2012-01-06 2013-01-04 System og fremgangsmåde til påvisning i perifert blod af rna'er der er forandret af lungecancer DK2809810T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261584097P 2012-01-06 2012-01-06
PCT/US2013/020383 WO2013103889A1 (en) 2012-01-06 2013-01-04 System and method of detecting rnas altered by cancer in peripheral blood

Publications (1)

Publication Number Publication Date
DK2809810T3 true DK2809810T3 (da) 2020-02-03

Family

ID=48745455

Family Applications (1)

Application Number Title Priority Date Filing Date
DK13733697.0T DK2809810T3 (da) 2012-01-06 2013-01-04 System og fremgangsmåde til påvisning i perifert blod af rna'er der er forandret af lungecancer

Country Status (12)

Country Link
US (2) US9422592B2 (da)
EP (1) EP2809810B1 (da)
JP (2) JP2015503356A (da)
AU (1) AU2013207385B2 (da)
CA (1) CA2860338C (da)
DK (1) DK2809810T3 (da)
ES (1) ES2769795T3 (da)
HU (1) HUE047739T2 (da)
IL (1) IL233163B (da)
PL (1) PL2809810T3 (da)
PT (1) PT2809810T (da)
WO (1) WO2013103889A1 (da)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3126529B1 (en) 2014-03-31 2020-05-27 Mayo Foundation for Medical Education and Research Detecting colorectal neoplasm
CA2965528A1 (en) 2014-11-14 2016-05-19 Liquid Genomics, Inc. Use of circulating cell-free rna for diagnosis and/or monitoring cancer
CN108350485A (zh) 2015-10-30 2018-07-31 精密科学发展有限责任公司 血浆dna的多重扩增检测测定以及分离和检测
AU2018266162A1 (en) * 2017-05-10 2020-01-02 Nantomics, Llc Circulating RNA for detection, prediction, and monitoring of cancer
WO2018226971A1 (en) * 2017-06-07 2018-12-13 Cedars-Sinai Medical Center Peptide compositions for immuno-oncology molecular imaging and targeted drug delivery
SG11202002711WA (en) 2017-10-12 2020-04-29 Nantomics Llc Cancer score for assessment and response prediction from biological fluids
AU2018365883A1 (en) 2017-11-07 2020-05-14 Nanthealth Labs, Inc. Targeted cell free nucleic acid analysis
AU2019403269A1 (en) * 2018-12-18 2021-06-17 Grail, Llc Methods for detecting disease using analysis of RNA
US11345967B2 (en) 2019-05-23 2022-05-31 Paradigm Diagnostics Tissue preparation using nuclease
AU2020336115A1 (en) * 2019-08-27 2022-04-14 Exact Sciences Corporation Characterizing methylated DNA, RNA, and proteins in subjects suspected of having lung neoplasia

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100236506B1 (ko) 1990-11-29 2000-01-15 퍼킨-엘머시터스인스트루먼츠 폴리머라제 연쇄 반응 수행 장치
CA2218875C (en) 1991-07-23 2000-11-07 The Research Foundation Of State University Of New York Improvements in the in situ pcr
KR0171154B1 (ko) 1995-04-29 1999-03-20 배순훈 특징점 기반 움직임 추정을 이용하여 비디오 신호를 부호화하는 방법 및 장치
US6040139A (en) 1995-09-19 2000-03-21 Bova; G. Steven Laser cell purification system
US6329179B1 (en) 1996-03-26 2001-12-11 Oncomedx, Inc. Method enabling use of extracellular RNA extracted from plasma or serum to detect, monitor or evaluate cancer
US6759217B2 (en) 1996-03-26 2004-07-06 Oncomedx, Inc. Method enabling use of extracellular RNA extracted from plasma or serum to detect, monitor or evaluate cancer
US7785842B2 (en) 1996-03-26 2010-08-31 Oncomedx, Inc. Comparative analysis of extracellular RNA species
US8043835B1 (en) 1996-03-26 2011-10-25 Oncomedx, Inc. Methods for detecting and monitoring cancer using extracellular RNA
US6100051A (en) 1997-06-27 2000-08-08 The United States Of America As Represented By The Department Of Health And Human Services Method utilizing convex geometry for laser capture microdissection
US8163524B2 (en) 1998-09-22 2012-04-24 Oncomedx, Inc. Comparative analysis of extracellular RNA species
US7767422B2 (en) 1998-09-22 2010-08-03 Oncomedx, Inc. Detection of 5T4 RNA in plasma and serum
US20040085443A1 (en) 2000-12-13 2004-05-06 Kallioniemi Olli P Method and system for processing regions of interest for objects comprising biological material
WO2003044215A2 (en) 2001-11-20 2003-05-30 Oncomedx, Inc. Methods for evaluating drug-resistance gene expression in the cancer patient
WO2003074069A2 (en) * 2002-03-07 2003-09-12 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with the n-formyl peptide receptor 1 (fpr 1)
WO2003102185A2 (en) 2002-05-30 2003-12-11 Telogene Inc. Methods and compositions for treating neoplasia relating to hnrnp a1 and a2 nucleic acid molecules
US7955846B2 (en) 2004-05-17 2011-06-07 The General Hospital Corporation Compositions comprising female germline stem cells and methods of use thereof
US20060051736A1 (en) 2004-08-19 2006-03-09 Applied Imaging Corp. Paraffin-control marker
EP2230315A1 (en) 2005-02-01 2010-09-22 AB Advanced Genetic Analysis Corporation Nucleic acid sequencing by performing successive cycles of duplex extension
US7405056B2 (en) 2005-03-02 2008-07-29 Edward Lam Tissue punch and tissue sample labeling methods and devices for microarray preparation, archiving and documentation
CA2633754C (en) 2006-01-05 2013-06-18 The Ohio State University Research Foundation Microrna-based methods and compositions for the diagnosis and treatment of solid cancers
US8252538B2 (en) 2006-11-01 2012-08-28 The Ohio State University MicroRNA expression signature for predicting survival and metastases in hepatocellular carcinoma
US8189882B2 (en) 2008-01-30 2012-05-29 Clarient, Inc. Automated laser capture microdissection
US8880351B2 (en) 2008-03-25 2014-11-04 General Electric Company Method and apparatus for analysis of tissue microarrays
EP3181705A1 (en) 2008-11-12 2017-06-21 Caris Life Sciences Switzerland Holdings GmbH Methods and systems of using exosomes for determining phenotypes
US8765383B2 (en) * 2009-04-07 2014-07-01 Genomic Health, Inc. Methods of predicting cancer risk using gene expression in premalignant tissue
WO2010123124A1 (ja) * 2009-04-24 2010-10-28 国立大学法人九州大学 固形がんの再発および予後因子、およびその臨床利用

Also Published As

Publication number Publication date
AU2013207385B2 (en) 2018-09-13
US20130196332A1 (en) 2013-08-01
EP2809810B1 (en) 2019-11-13
CA2860338C (en) 2022-08-02
US20160333424A1 (en) 2016-11-17
HUE047739T2 (hu) 2020-05-28
PT2809810T (pt) 2020-02-14
EP2809810A1 (en) 2014-12-10
JP2015503356A (ja) 2015-02-02
US9422592B2 (en) 2016-08-23
IL233163A0 (en) 2014-07-31
CA2860338A1 (en) 2013-07-11
WO2013103889A1 (en) 2013-07-11
AU2013207385A1 (en) 2014-07-10
PL2809810T3 (pl) 2020-07-27
EP2809810A4 (en) 2015-12-02
IL233163B (en) 2019-02-28
ES2769795T3 (es) 2020-06-29
JP2019162102A (ja) 2019-09-26

Similar Documents

Publication Publication Date Title
DK2809810T3 (da) System og fremgangsmåde til påvisning i perifert blod af rna'er der er forandret af lungecancer
BR112013028966A2 (pt) sistema fotobiorreator de calha em v e método de uso
DK2914743T3 (da) Udvinding, detektering og kvantificering af lille rna
DK2852680T3 (da) Fremgangsmåder og processer til ikke-invasiv evaluering af genetiske variationer
DK2681227T3 (da) Phosphoramidatderivater af 5-fluor-2'-deoxyuridin til anvendelse i behandlingen af cancer
BRPI1008909A2 (pt) métodos e sistema de tratamento de veia
EP2779907A4 (en) SYSTEM AND METHOD FOR MEDICAL MEASUREMENT
DK3358011T3 (da) Peptid til inducering af regenerering af væv og anvendelse deraf
BRPI1007758A2 (pt) sistema e método de medição de mudanças de volume arterial de um segmento de membro
BR112013021971A2 (pt) sistema médico e método.
BR112013021984A2 (pt) métodos e sistema de tratamento de poço
DK2743670T3 (da) Fejldetekteringssystem og tilhørende metode
BR112013022764A2 (pt) sistema médico e método
DK3035849T3 (da) Lægemiddeleluering til beskyttelse in vivo af biosensor-analysander
GB201400630D0 (en) System and method to measure or generate an electriacl field downhole
DK2815769T3 (da) Fam19a5 til anvendelse i diagnosticering og behandling af skader på centralnervesystemet
DK2632954T4 (da) Midler og fremgangsmåder til behandling af dlbcl
DK2663336T3 (da) Fremgangsmåder og reagenser til effektiv og targeteret afgivelse af terapeutiske molekyler til CXCR4-celler
BR112013027414A2 (pt) bolão de cateter e método para revestimento do mesmo
BR112013003528A2 (pt) ''solução para extrair rna e métodos para extrair rna''
DE102011085408A8 (de) Meßwandler sowie damit gebildetes Meßsystem
DK2719005T3 (da) Fremgangsmåde og system til genindvinding af bestanddele af batterier
CL2013002863A1 (es) Sistema y metodos de transaccion financiera.
DK2800575T3 (da) Behandling af subarachnoidalblødning og iskæmi
DK2834643T3 (da) Fremgangsmåde til behandling af blod, blodprodukter og organer